[ad_1]
Company News of Thursday, March 21, 2019
Source: Hello tomorrow
2019-03-21
RxAll won the ultimate challenge
After two full days of Deeptech innovations, Hello Tomorrow has finally announced the 12 winners of its Global Challenge, an international start-up competition for early-stage scientists and Deeptech entrepreneurs.
The global challenge Throughout the year, Hello Tomorrow collaborates with leading universities, research laboratories, accelerators and incubators around the world to find entrepreneurs early on that develop new scientific and technological solutions.
This year, the Global Challenge registered a record number of 4,500 applications from 119 countries, indicating that new technology development is more widespread than ever before.
"The variety of startup applications we've received this year shows that Deeptech innovation can come from anywhere in the world and that it can provide solutions to many problems major challenges facing our society today, "said co-founder and co-CEO of Bonjour demain.
"At Hello Tomorrow, we are working to ensure that these startups have the right conditions to create a large-scale impact."
RxAll Wins Hello Tomorrow Challenge for Portable Drug Authenticator
RxAll, the Nigerian start-up that is tackling the global problem of counterfeit medicines, has received the Global Challenge prize of € 100,000 from BNP Paribas, Hello Tomorrow's global partner.
RxAll's digital platform allows anyone to test the quality of their medicines using a portable nano scanner and a mobile app. Their exclusive machine learning algorithm reads the scan from the nano scanner, identifies the drug and evaluates the quality level, records the test result in a multi-channel registry, and returns the quality report to the mobile app. 20 seconds.
"It's a long way from the death of a fake drug 15 years ago and your presence today," said RxAll CEO Adebayo Alonge. "The solution we have today means that no one should suffer what I've done."
Fake drugs represent a $ 30 billion industry that poses a significant risk to patients around the world, especially in developing countries.
In 2017, fake medicines have resulted in hundreds of thousands of deaths worldwide and centralized regulatory oversight is often unable to track the speed at which counterfeiters produce new drugs.
The RxAll platform solves this problem by providing real-time drug authentication in the palm of your hand.
The trip to the world summit. The three biggest African startups, RxAll, Tambua Intelligent Diagnostics and Aircraft Hijacker, have been selected to play their face-to-face throws on the Arena stage on Friday, November 16, 2018. Cash prize, a chance to represent Africa on the stage in Paris and compete for the grand prize of 100,000 euros.
After 3 minutes of play, RxAll attracted industry leaders and experts to bring out the winners of the digital health circuit.
Each of the winners in the 12 tracks had a minute to express themselves. The tension on the competition scene was palpable. Finally, RxAll was announced winner of the grand prize.
Big winners of the night
Bound4Blue (Spain) Receives Air France "Aeronautics" Award
KLM. Bound4blue enables the commercial shipping industry to be more efficient thanks to its rigid wing system that reduces fuel consumption and environmental impact, whether tankers, cargo ships or ships. fishing boats.
Wing technology is needed to maintain the financial viability of the shipping industry while improving its environmental sustainability. It must be used for both existing and new vessels.
Insightness (Switzerland) received the "Data and Artificial Intelligence" award from Hello Tomorrow. Insightness develops highly efficient computer vision systems for the devices of tomorrow. Their primary market is mixed reality (MR), where they provide one of the missing ingredients for its mbadive adoption: the immersive interaction.
Their technology is MR for what the multi-touch screen is for the smartphone or the mouse is for the PC.
RxAll (Nigeria) received the WeHealth Digital Health Award from
Servier. RxAll is a digital platform that allows anyone to test the quality of their medications with the help of an exclusive IoT nano scanner and mobile application. The proprietary learning algorithm of RxAll reads the scan from the IoT nano
scanner, identifies the drug and badesses its level of quality. It saves the test result in a big book and returns the quality report to the mobile application in 20 seconds.
Coreshell (United States) received the Air Liquide Energy Award. Coreshell
Technologies introduces new thin-film coatings in lithium-ion batteries (LIB) to improve energy density, safety and, ultimately, the cost of energy storage.
Coreshell's nanocoated electrode coatings solve the most important problem in today's batteries as well as in future innovative chemicals by protecting against degradation reactions leading to loss of capacity and thermal overheating.
Coreshell hopes to become the key technology enabling lithium-ion batteries to thrive in today's electrified society.
Fauna Photonics (Denmark) received the Food, Agriculture and Environment Award
Invivo Award. Fauna Photonics is developing a smart sensor solution to map insects for the agricultural sector, helping farmers increase yields while reducing their reliance on chemicals. Their smart sensor solution allows for digital mapping of insect populations to help farmers determine when and where to spray insecticides.
X-Therma Inc. (USA) received the Global Health Award from G4A Bayer. XTherma Inc. solves the main problems related to the storage of biological products using convergent biomimetic nanosciences. The company manufactures highly advanced new chemical technologies to solve the long-standing problem of cold storage and transport of biological cells, tissues and organs. X-Therma enables essential biomanufacturing processes, safer transportation and a long-term biobank for advanced cell therapies, in vitro fertilization, organ transplants and other areas of regenerative medicine. rapid growth.
Dust BioSolutions (Germany) received the "Industrial Biotech" award
of DSM. Dust BioSolutions creates biological binders for industrial applications with a focus on agriculture, infrastructure and mining. Their first product controls dust in the global mining industry and their applications help established industries increase their sustainability, profitability and innovation.
Echoring (Germany) received the Hello Industry 4.0 Award
Tomorrow. EchoRing ™ is a revolutionary wireless software technology designed for applications that require both critical performance and robustness. Based on pbading chips and mbadive cooperation, EchoRing ™ enables deterministic and real-time wireless communications (up to 1 ms) with performance similar to that of a cable.
Soundskrit (Canada) Receives the Solvay & Solvay "New Materials" Award
Ventures. Soundskrit has designed a patent-protected microphone membrane that can separate and locate sounds from multiple directions, all with one microphone, without compromising size or quality. The company's patented microphone membrane can separate and locate sounds from multiple directions with a single microphone, without compromising size or quality.
LevelUp (Taiwan) received the "Mobility" award from Novares.NiveauUp is
enabling extremely fast charging of LI-ion battery cells, allowing them to charge 10 times faster, 3 times longer and be lighter than packets. Their technology can penetrate the manufacturing ecosystem of existing Li-ion batteries in a transparent and cost-effective way.
Atomos (USA) has received the "New Space" award from ArianeWorks, ArianeGroup and CNES. Atomos builds spacecraft to move other spacecraft, accurately places new orbital badets, recovers misplaced satellites, removes dead satellites and opens deep space access. Atomos builds a
fleet of spaceships to move satellites and other badets between orbits and to other destinations through efficient electric propulsion. The vision is to become the logistics provider of the solar system.
Ilya Pharma (Sweden) received the L'Oreal Wellbeing Award. Ilya Pharma develops new generation biological products to treat wounds of the skin and mucous membranes.
Ilya Pharma's therapies target both acute and chronic wounds, which are particularly problematic for people with diabetes. Ilya Pharma offers a more effective and highly cost-effective treatment compared to treatment with conventional biologics, which should enter the wound care market.
Source link
